Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 6—June 2005

Research

Emergence and Spread of Streptococcus pneumoniae with erm(B) and mef(A) Resistance

David J. Farrell*Comments to Author , Stephen G. Jenkins†, Steven D. Brown‡, Manish Patel§, Bruce S. Lavin§, and Keith P. Klugman¶#
Author affiliations: *G.R. Micro Ltd, London, United Kingdom; †Mount Sinai School of Medicine, New York, New York, USA; ‡Clinical Microbiology Institute, Wilsonville, Oregon, USA; §sanofi-aventis, Bridgewater, New Jersey, USA; ¶Emory University, Atlanta, Georgia, USA; #University of the Witwatersrand, Johannesburg, South Africa

Main Article

Table 2

Proportion of erythromycin-resistant Streptococcus pneumoniae isolates collected from years 1 to 3 of the PROTEKT US study with the dual mef(A)+erm(B) genotype according to patient age

Patient age (y) No. erm(B)+mef(A)–positive/no. erythromycin-resistant (%)
Year 1 Year 2 Year 3
0–2 88/825 (10.7) 118/640 (18.4) 170/710 (23.9)
3–14 52/388 (13.4) 47/365 (12.9) 84/409 (20.5)
15–64 98/1,106 (8.9) 95/972 (9.8) 151/1,173 (12.9)
>64 58/727 (8.0) 70/755 (9.3) 98/794 (12.3)
Not specified
8/87 (9.2)
5/61 (8.2)
17/91 (18.7)
Total 304/3,133 (9.7) 335/2,793 (12.0) 520/3,177 (16.4)

Main Article

TOP